We thank Jui-Teng Lin 1 for his interest in our recent work studying riboflavin (RF)-UVA-assisted corneal collagen crosslinking (CXL). 2 His comments on our data with a mathematic equation bring new perspectives to the corneal CXL biology.
Lin's mathematical formula, R(z,t) ¼ 2a/I(z,t)C(z,t), successfully models such RF-UVA-mediated CXL photokinetics. 1 The efficacy of CXL indicated by Lin's ''normalized RF concentration'' profile was positively correlated to UVA dosage.
Using second harmonic generation (SHG) microscopy, we further reported that the most effective zone of RF-UVA CXL was confined to 150 to 250 lm irrespective of RF dosage. 2 In comparison, Chai et al. 6 indicated that the effective CXL region was restricted to the anterior 300 lm and not correlated to the UVA irradiation dosage. Such a depth threshold of CXL is well explained by Lin's formula. Analytically, he shows that the dose effect of UVA irradiation for CXL mainly takes place in a stromal depth of 150 to 250 lm.
Clinically, the safety range between therapeutic and phototoxic UVA irradiation doses is largely reduced when CXL treatment is applied to thin corneas with a limited UVA penetration depth. As commonly accepted, the safety threshold for corneal thickness in CXL therapy is set to be 400 lm. The effective CXL zone up to 300 lm, collectively supported by our SHG image data, Mastropasqua's HPLC results, and Lin's mathematical model, justifies such a case selection criterion. Future laboratory studies will merit the clinical ramification of Lin's mathematical CXL model.
Maria Laggner
1
